IRIS
LUGHEZZANI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.652
AS - Asia 8.507
EU - Europa 2.565
SA - Sud America 2.034
AF - Africa 511
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 14
Totale 25.305
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.390
SG - Singapore 5.295
BR - Brasile 1.665
CN - Cina 1.249
VN - Vietnam 970
FI - Finlandia 493
IE - Irlanda 385
IT - Italia 361
NG - Nigeria 327
DE - Germania 311
FR - Francia 248
HK - Hong Kong 204
GB - Regno Unito 190
AR - Argentina 150
IN - India 139
CA - Canada 137
NL - Olanda 119
TR - Turchia 112
BD - Bangladesh 89
SE - Svezia 89
RU - Federazione Russa 83
MX - Messico 74
ID - Indonesia 64
EC - Ecuador 58
IQ - Iraq 58
JP - Giappone 54
ZA - Sudafrica 52
UA - Ucraina 44
CL - Cile 41
VE - Venezuela 38
ES - Italia 34
IL - Israele 33
PL - Polonia 30
SA - Arabia Saudita 29
CO - Colombia 28
EG - Egitto 27
PH - Filippine 27
PK - Pakistan 27
PY - Paraguay 27
UZ - Uzbekistan 24
AU - Australia 22
DZ - Algeria 22
KE - Kenya 22
MA - Marocco 20
MK - Macedonia 20
RO - Romania 20
BE - Belgio 19
CZ - Repubblica Ceca 17
JO - Giordania 15
NP - Nepal 15
AT - Austria 14
KZ - Kazakistan 12
TN - Tunisia 12
MY - Malesia 11
TW - Taiwan 11
UY - Uruguay 11
CH - Svizzera 10
DO - Repubblica Dominicana 10
A2 - ???statistics.table.value.countryCode.A2??? 9
LT - Lituania 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
GR - Grecia 8
IR - Iran 8
MO - Macao, regione amministrativa speciale della Cina 8
PT - Portogallo 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
ET - Etiopia 7
LB - Libano 7
PS - Palestinian Territory 7
AL - Albania 6
BO - Bolivia 6
HN - Honduras 6
AO - Angola 5
CG - Congo 5
HU - Ungheria 5
JM - Giamaica 5
PA - Panama 5
RS - Serbia 5
TH - Thailandia 5
BG - Bulgaria 4
DK - Danimarca 4
GT - Guatemala 4
MD - Moldavia 4
NO - Norvegia 4
SN - Senegal 4
BY - Bielorussia 3
CR - Costa Rica 3
EU - Europa 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
LV - Lettonia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
CI - Costa d'Avorio 2
EE - Estonia 2
Totale 25.273
Salva come PNG Salva come JPEG
Città #
Singapore 2.370
Wilmington 1.824
Chandler 1.314
The Dalles 800
Ashburn 738
San Mateo 717
Shanghai 594
Ann Arbor 512
Dallas 501
Helsinki 491
San Jose 447
Dublin 384
Leawood 330
Lawrence 327
Princeton 327
Benin City 325
Ho Chi Minh City 322
Beijing 253
Hanoi 225
Boardman 222
New York 195
Paris 195
Fairfield 186
Woodbridge 186
Hong Kong 183
Milan 165
São Paulo 105
Los Angeles 99
Amsterdam 95
London 90
Santa Clara 81
Toronto 71
Kocaeli 66
Rio de Janeiro 60
Orem 55
Da Nang 53
Council Bluffs 51
Haiphong 51
Seattle 48
San Diego 41
Belo Horizonte 37
Norwalk 35
Brasília 34
Columbus 33
Phoenix 32
Falkenstein 30
Campinas 29
Curitiba 29
Munich 27
Pune 27
Montreal 24
Biên Hòa 23
Frankfurt am Main 23
Porto Alegre 23
Tashkent 23
Chennai 22
Johannesburg 22
Manchester 22
Warsaw 22
Naples 21
Tokyo 21
Brooklyn 20
Nairobi 20
Salvador 20
Thái Bình 20
Buffalo 19
Guayaquil 19
New Delhi 19
Falls Church 18
Guarulhos 18
Santiago 18
Brussels 17
Hải Dương 17
Mexico City 17
Moscow 17
Ribeirão Preto 16
Des Moines 15
Dhaka 15
Quito 15
Atlanta 14
Redmond 14
Takamatsu 14
Amman 13
Can Tho 13
Fortaleza 13
Monmouth Junction 13
Recife 13
Riyadh 13
Asunción 12
Boston 12
Cairo 12
Manaus 12
Mumbai 12
Praia Grande 12
Stockholm 12
Baghdad 11
Jakarta 11
Kyiv 11
Olomouc 11
Phủ Lý 11
Totale 16.237
Salva come PNG Salva come JPEG
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 203
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer. 170
"En Bloc" Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study 168
Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): mid-term results from a Bladder cancer Italian Active Surveillance (BIAS) project. 157
137 PHI (Prostate Health Index) and %p2PSA for prediction of prostate cancer in men younger than 60 years of age. A nested-case control study from PROpsa Multicentric European Study (PROMEtheuS project) 156
855 Definition of the Limit of Detection (LoD) for serum isoform [−2]proPSA in patients with recurrent prostate cancer after radical prostatectomy: An analytic study 133
[-2]PROPSA FOR PREDICTION OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: PRELIMINARY RESULTS FROM AN OBSERVATIONAL COHORT STUDY 129
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 128
-2PROPSA, %-2PROPSA AND PHI (PROSTATE HEALTH INDEX) CORRELATE WITH CANCER AGGRESSIVENESS IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY 127
Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancer 126
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project 124
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 123
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 123
[Focal therapy and prostate cancer]. 122
Accuracy of p2PSA and derivatives (%p2PSA and PHI) in predicting prostate cancer in obese men from a multicenter European study 122
63 Preoperative predictors of positive surgical margins in a contemporary cohort of patients treated with bilateral nerve sparing robot assisted laparoscopic radical prostatectomy 121
54 Safety and efficacy of robot-assisted laparoscopic partial nephrectomy during the learning curve in a high volume urological center 119
254 Margin, Ischemia, and Complications (MIC) System to report perioperative outcomes of robot-assisted partial nephrectomy: A European Multicenter Observational Study (EMOS project) 118
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 116
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project 110
[-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER. A SINGLE HIGH-VOLUME CENTER EXPERIENCE 108
Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature. 108
Re: Comparative Analysis of Transperineal Template Saturation Prostate Biopsy Versus Magnetic Resonance Imaging Targeted Biopsy with Magnetic Resonance Imaging-Ultrasound Fusion Guidance 105
Clinical and pathological predictors of persistent T1 HG at second resection 102
Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses 102
A Population-based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States 102
A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma REPLY 102
An observational study of the use of beclomethasone dipropionate suppositories in the treatment of lower urinary tract inflammation in men 101
Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination 100
Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis 100
[The added value of robotic surgery]. 99
HOW TO SIMPLIFY PATIENT POSITIONING AND PORT PLACEMENT DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) 98
Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review 97
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma 97
ACTIVE SURVEILLANCE FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 96
A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma 96
A POPULATION-BASED ANALYSIS OF PERIOPERATIVE COMPLICATIONS AND MORTALITY ASSOCIATED WITH CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA 96
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) REPLY 96
Re: Guazzoni et al.: Oncologic Results of Laparoscopic Renal Cryoablation for Clinical T1a Tumors: 8 Years of Experience in a Single Institution (Urology 2010; 76: 624-629) Reply 93
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 93
Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study 90
A Contemporary Population-Based Assessment of the Rate of Lymph Node Dissection for Penile Carcinoma 90
The Management of Small Renal Masses: Renal Anatomy and Physiology 90
TRANSPERITONEAL LAPAROSCOPIC ADRENALECTOMY: SINGLE INSTITUTION 16-YEAR EXPERIENCE 88
Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions 88
Urethral Lift for Benign Prostatic Hyperplasia: A Comprehensive Review of the Literature 88
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2299 patients 88
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence 88
Xpert Bladder Cancer Detection in Emergency Setting Assessment (XESA Project): A Prospective, Single-centre Trial 87
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) 87
IMPACT OF MINIMALLY INVASIVE APPROACH ON THE PROBABILITY OF EARLY COMPLETE FUNCTIONAL RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY 87
Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study 87
Highly-trained dogs' olfactory system for detecting biochemical recurrence following radical prostatectomy 86
Robot-assisted laparoscopic partial nephrectomy with Alf–X Robot on pig model 86
Reply to Marc A. Bjurlin, Lee C. Zhao, and Michael D. Stifelman's Letter to the Editor Re: Nicolo Maria Buffi, Giovanni Lughezzani, Rodolfo Hurle, et al. Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.022 86
Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting 85
A Population-based Assessment of Perioperative Mortality After Nephroureterectomy for Upper-tract Urothelial Carcinoma 85
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 84
Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups 84
Predicting Cancer-specific Mortality After Radical Prostatectomy: Still a Long Way To Go 83
MIDDLE TERM FOLLOW-UP RESULTS OF MAGNETIC RESONANCE IMAGING EVALUATION AFTER FOCAL THERAPY FOR PROSTATE CANCER 82
Functional outcomes after robot-assisted radical prostatectomy in young patients (≤ 55 yrs) with prostate cancer: Is surgery perfect in the best candidates? 82
Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guerin: experience of a single center 82
Oncologic results of laparoscopic renal cryoablation for clinical T1a tumors: 8 years of experience in a single institution. 82
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 82
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder Tumor 81
POPULATION-BASED COMPARISON OF CANCER SPECIFIC MORTALITY AFTER LOCAL TUMOR ABLATION OR NON-ACTIVE TREATMENT FOR T1A KIDNEY CANCER: A COMPETING RISK ANALYSIS 81
DIAGNOSTIC ACCURACY OF [-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER 81
How Should We Report Incontinence After Radical Prostatectomy? 80
Comparison of PHI (Prostate Health Index) and PCA3 assay in the prediction of prostate biopsy (PBx) outcome in patients who have undergone initial and repeated prostatic biopsies 80
P2PSA AND DERIVATIVES (% P2PSA AND PHI) ACCURATELY PREDICT PROSTATE CANCER IN OBESE MEN FROM A MULTICENTER PROSPECTIVE EUROPEAN STUDY 80
Clinical performance of prostate health index in men with tPSA>10ng/ml: Results from a multicentric European study. 80
Is Robotic Surgery Unnecessary for Adrenalectomy? Weighting the Pros and Cons of the Robotic Approach 79
INTRAFASCIAL TECHNIQUE OFFERS IMPROVED FUNCTIONAL OUTCOMES IN PATIENTS TREATED WITH BILATERAL NERVE SPARING ROBOTIC RADICAL PROSTATECTOMY 79
UROLOGIST LEARNING CURVE HAS AN IMPACT ON INCREASING PROBABILITY OF CLINICALLY SIGNIFICANT CANCER DETECTION RATE AT MPMRI-TRUS FUSION TARGET BIOPSY: A PROSPECTIVE STUDY IN A SINGLE HIGH VOLUME INSTITUTION 79
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study 79
Robotic assisted radical prostatectomy in morbidly obese patients: how to create a cost-effective adequate optical trocar 79
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: Pure versus non-pure CIS 79
Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer 79
MAGNETIC RESONANCE IMAGING ALONE SHOULD NOT BE CONSIDERED AS A STAND-ALONE TEST FOR DISEASE RECLASSIFICATION OF MEN IN ACTIVE SURVEILLANCE 78
The relationship between continence and perineal body tone before and after radical prostatectomy: A pilot study 78
Reply from Authors re: Monique J. Roobol. Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely? Eur Urol 2011;60:223-5 and re: Carvell T. Nguyen, Michael W. Kattan. How to Tell If a New Marker Improves Prediction 78
Bladder Cancer and Urothelial Impairment: The Role of TRPV1 as Potential Drug Target 78
XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY 78
DIAGNOSTIC ACCURACY OF TARGETED PROSTATE BIOPSIES: RESULTS FROM A PROSPECTIVE TRIAL COMPARING MICRO-ULTRASOUND WITH MULTIPARAMETRIC MRI FOR THE DETECTION OF PROSTATE CANCER 78
Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and SMARCB1/INI1 Deficiency, Broadening the Spectrum of Medullary Carcinoma 78
Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer 77
UP-DATE OF PATHOLOGICAL OUTCOME AND SUBJECTIVE DEFINITION OF FAILURE FOR PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER: RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 77
Reply to Marc A. Bjurlin, Lee C. Zhao, and Michael D. Stifelman's Letter to the Editor Re: Nicolò Maria Buffi, Giovanni Lughezzani, Rodolfo Hurle, et al. Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions. 76
Complications and Quality of Life After Template-assisted Transperineal Prostate Biopsy in Patients Eligible for Focal Therapy 76
Intra-operative frozen section analysis to increase the rate of nerve-sparing procedures without compromising cancer control: Results from a contemporary population of patients treated with robotic assisted radical prostatectomy 76
NEPHRON SPARING SURGERY FOR THE TREATMENT OF SMALL RENAL MASSES: COMPARISON BETWEEN OPEN PARTIAL NEPHRECTOMY, LAPAROSCOPIC PARTIAL NEPHRECTOMY AND LAPAROSCOPIC CRYOABLATION 76
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 76
Reliability of the da Vinci robotic surgical system: a systematic review and pooled analysis of technical failures 75
Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study 75
Impact of prostate cancer screening in European ancestry un‐affected men with germline DNA repair pathogenic variants 75
THE EFFECT OF PREOPERATIVE CANCER AGGRESSIVENESS ON LEARNING CURVE AMONG HIGH VOLUME SURGEONS PERFORMING RADICAL RETROPUBIC PROSTATECTOMY. 75
Locally-advanced prostate cancer in the elderly: should we revisit our treatment paradigms? 75
Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project 75
INTRAFASCIAL BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: DOES THE ROBOTIC-ASSISTED APPROACH PREDISPOSE TO HIGHER RISK OF POSITIVE SURGICAL MARGINS? IMPORTANCE OF PATIENT SELECTION 75
Totale 9.554
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.625
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.625
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021759 0 0 0 0 0 0 0 0 0 369 2 388
2021/20221.687 65 39 32 367 17 21 48 254 151 210 426 57
2022/20234.002 723 118 403 404 381 311 16 292 671 381 259 43
2023/20242.286 184 266 446 117 63 204 141 174 39 42 232 378
2024/20254.174 90 79 48 71 118 422 192 456 599 1.012 473 614
2025/20269.999 1.431 609 833 1.388 354 437 3.009 686 651 601 0 0
Totale 25.666